Literature DB >> 3497596

Nail pigmentation changes associated with azidothymidine (zidovudine).

P A Furth, A M Kazakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3497596     DOI： 10.7326/0003-4819-107-2-350

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Antiretroviral therapy: reverse transcriptase inhibition.

Authors:  K J Connolly; S M Hammer
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Diffuse hyperpigmentation associated with acquired immunodeficiency syndrome.

Authors:  S A Peter; Y F Brignol; M H Razavi; N Greeley
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

Review 3.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 4.  Antiviral therapy in human immunodeficiency virus infection.

Authors:  E Sandström
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 5.  The future of antiviral chemotherapy.

Authors:  S Crowe; J Mills
Journal:  Dermatol Clin       Date:  1988-10       Impact factor: 3.478

6.  Zidovudine-induced nail pigmentation in a 12-year-old boy.

Authors:  Sanjeevani M Chawre; Shraddha M Pore; Manish B Nandeshwar; Nausheen M Masood
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.